670 related articles for article (PubMed ID: 18842730)
1. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
Tomaras GD; Yates NL; Liu P; Qin L; Fouda GG; Chavez LL; Decamp AC; Parks RJ; Ashley VC; Lucas JT; Cohen M; Eron J; Hicks CB; Liao HX; Self SG; Landucci G; Forthal DN; Weinhold KJ; Keele BF; Hahn BH; Greenberg ML; Morris L; Karim SS; Blattner WA; Montefiori DC; Shaw GM; Perelson AS; Haynes BF
J Virol; 2008 Dec; 82(24):12449-63. PubMed ID: 18842730
[TBL] [Abstract][Full Text] [Related]
2. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.
Amos JD; Himes JE; Armand L; Gurley TC; Martinez DR; Colvin L; Beck K; Overman RG; Liao HX; Moody MA; Permar SR
J Virol; 2015 Sep; 89(18):9485-98. PubMed ID: 26157116
[TBL] [Abstract][Full Text] [Related]
3. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.
Liu P; Overman RG; Yates NL; Alam SM; Vandergrift N; Chen Y; Graw F; Freel SA; Kappes JC; Ochsenbauer C; Montefiori DC; Gao F; Perelson AS; Cohen MS; Haynes BF; Tomaras GD
J Virol; 2011 Nov; 85(21):11196-207. PubMed ID: 21865397
[TBL] [Abstract][Full Text] [Related]
4. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
Forthal DN; Landucci G; Daar ES
J Virol; 2001 Aug; 75(15):6953-61. PubMed ID: 11435575
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.
Yates NL; Stacey AR; Nolen TL; Vandergrift NA; Moody MA; Montefiori DC; Weinhold KJ; Blattner WA; Borrow P; Shattock R; Cohen MS; Haynes BF; Tomaras GD
Mucosal Immunol; 2013 Jul; 6(4):692-703. PubMed ID: 23299618
[TBL] [Abstract][Full Text] [Related]
6. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
[TBL] [Abstract][Full Text] [Related]
7. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
Gallerano D; Ndlovu P; Makupe I; Focke-Tejkl M; Fauland K; Wollmann E; Puchhammer-Stöckl E; Keller W; Sibanda E; Valenta R
PLoS One; 2015; 10(2):e0117204. PubMed ID: 25658330
[TBL] [Abstract][Full Text] [Related]
9. Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein.
Alexander MR; Sanders RW; Moore JP; Klasse PJ
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1160-5. PubMed ID: 26086186
[TBL] [Abstract][Full Text] [Related]
10. Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.
Martinez P; Sundling C; O'Dell S; Mascola JR; Wyatt RT; Karlsson Hedestam GB
Sci Rep; 2015 Mar; 5():8925. PubMed ID: 25762407
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.
Jin S; Ji Y; Wang Q; Wang H; Shi X; Han X; Zhou T; Shang H; Zhang L
Retrovirology; 2016 Feb; 13():12. PubMed ID: 26883323
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
13. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.
Skrabal K; Saragosti S; Labernardière JL; Barin F; Clavel F; Mammano F
J Virol; 2005 Sep; 79(18):11848-57. PubMed ID: 16140761
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
Burrer R; Haessig-Einius S; Aubertin AM; Moog C
Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596
[TBL] [Abstract][Full Text] [Related]
16. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
17. Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.
Zhang H; Huang Y; Fayad R; Spear GT; Qiao L
J Virol; 2004 Aug; 78(15):8342-8. PubMed ID: 15254206
[TBL] [Abstract][Full Text] [Related]
18. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
19. Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women.
Sacha CR; Vandergrift N; Jeffries TL; McGuire E; Fouda GG; Liebl B; Marshall DJ; Gurley TC; Stiegel L; Whitesides JF; Friedman J; Badiabo A; Foulger A; Yates NL; Tomaras GD; Kepler TB; Liao HX; Haynes BF; Moody MA; Permar SR
Mucosal Immunol; 2015 Mar; 8(2):316-26. PubMed ID: 25100291
[TBL] [Abstract][Full Text] [Related]
20. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
Gasper-Smith N; Crossman DM; Whitesides JF; Mensali N; Ottinger JS; Plonk SG; Moody MA; Ferrari G; Weinhold KJ; Miller SE; Reich CF; Qin L; Self SG; Shaw GM; Denny TN; Jones LE; Pisetsky DS; Haynes BF
J Virol; 2008 Aug; 82(15):7700-10. PubMed ID: 18508902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
